To study in vivo the contribution of different thymic epithelial cells to T-lymphocyte differentiation, we have established several nontransformed thymic epithelial cell lines and developed an in vivo assay, not involving exposure to drugs or radiation, that permitted us to study the capacity of these epithelial lines to support T-cell differentiation. We found that cell lines EA2 and ET, which express markers of cortical epithelial cells, produce interleukin 7 mRNA and after being 
The thymus provides a highly efficient environment for the development of early T lymphocytes into mature antigenspecific T lymphocytes (1) (2) (3) . The process of T-cell development within the thymus can be divided in two phases. (i) The first phase includes events leading to expression of the T-cell receptor (TCR) complex for recognition of antigen (TCR/CD3). (ii) In the second phase TCR/CD3+ thymocytes are selected for recognition of antigen in the context of self-major histocompatibility complex (MHC) (4) and selected against recognition of self-antigen plus self-MHC (5) . Besides lymphoid cells, the thymus contains epithelial cells, macrophages, dendritic cells, and fibroblasts (6) . Although different nonlymphoid cell types play a role in the second phase of thymocyte development (for reviews, see refs. 7 and 8), little is known about the contribution of these cells to the first phase of thymocyte development.
We have established in culture and characterized several nontransformed cell lines from thymic epithelial cells and have also developed an in vivo assay, not involving exposure to drugs or radiation, permitting us to assess the capacity of these thymic epithelial lines to support T-cell differentiation.
The results of such studies are the subject of the present report.
MATERIALS AND METHODS
Mice. Athymic nude mice used were NIH SwissII carrying the three mutations nude, xid, and beige (Institute for Biomedical Research, Fullinsdorf, Switzerland), BALB/c nu/ nu, and C57BL/6 nu/nu (Bomholgard, Ryi, Denmark). All mice were 3-4 weeks old at initiation of experiments.
Antibodies. Biotin-or fluorescein isothiocyanate (FITC)-coupled anti-Thyl.2, anti-CD8, and phycoerythrin-labeled anti-CD4 were purchased from Becton Dickinson. Biotin-or FITC-conjugated anti-CD3e chain (hybridoma 145-2C11), anti-TCRac (hybridoma 57-597), anti-pan-TCR'y6 (hybridoma GL3), anti-B220 (hybridoma 14.8) , anti-Pro-T lymphocytes (hybridomas JOR037-5 and JOR075). MHC class Id (hybridoma 31-3-45) , MHC class 11bd (hybridoma M5/114 and MKD6) were prepared in our laboratory as described (9) . Monoclonal antibodies with the following specificities were used in the form of hybridoma culture supernatants: Pgp-1 (hybridoma I42/5), ICAM 16-day (C57BL/6 x BALB/c)F1 mouse embryo, which is described in detail elsewhere (10) . The epithelial cell lines were propagated in D-valine-containing Eagle's minimal essential medium (GIBCO) [supplemented with 5% of a previously selected batch of fetal calf serum (no. 0537770, Readysysteme, Bad Zurzach, Switzerland), 2-mercaptoethanol (5 X lo-M), fungizone (2.5 ,ug/ml), Gentamycin (50 ,ug/ml), and L-glutamine (2 mM)] in Costar 6-well plates (no. 3506), as described (10) . Aliquots of the several epithelial cell lines were frozen in culture medium/20% fetal calf serum/14% dimethyl sulfoxide.
The capacity of supporting T-cell differentiation in vivo by the EA2, ET, and EB3 epithelial lines was assessed in the following assay. Mice were anesthetized by i.p. injection of Avertin (Hoffmann-La Roche). A small (0.5-1 cm long) incision was made in the skin and subcutaneous tissue covering the spleen area, and then a very small cut (<0.5 cm) was made through the peritoneum near the spleen. With forceps introduced through the incision, the spleen was (20) and the 83-actin probe (1.1-kb Pst I-Pst I fragment). The probes were isolated inserts labeled with 32p by using a random-primer DNA-labeling kit (Boehringer Mannheim).
RNA blotting to Zeta-Probe nylon membranes, hybridization procedure, and autography were accomplished following the recommendations of the manufacturers (Bio-Rad).
RESULTS AND DISCUSSION
We have established in culture five epithelial lines from the thymus of (C57BL/6 x BALB/c)Fj newborn mice by the same procedure used to obtain ET thymic epithelial line (10) . Functionally, the five additional epithelial lines can be divided into two groups-lines EA2 and EH1 in one group and lines EB3, ED7, and EG9 in the other. We describe here studies done with EA2 and EB3 lines, as well as with the established thymic epithelial ET line (10) . These cell lines are not transformed malignant cells in that they do not form tumors in athymic nude mice during 16-week observation. (22, 23) . EA2 and ET but not EB3 cells bound the 4F1 antibody reactive with cortical epithelial cells (23) (Fig. la and Table 1 ). All three lines were negative for ER-TR4, a marker for some cortical epithelial cells (22) , and ER-TR7, an antigen expressed on thymic fibroblasts (22) . These three lines were also negative for surface markers present on T lymphocytes (CD4, CD8, CD3), T-cell progenitors (JOR075, JOR037-5), B lymphocytes (B-220, IgM), myeloid lineage cells (F4/80, Mac-1, Mac-2, BP-2), or dendritic cells (NLDC145). None of the cell lines bear class I or II MHC proteins, but they do so after treatment with interferon y at 37°C for 3 days. EA2, ET, and EB3 cell lines are Thy-1+ Pgp-1+ ICAM-1+ ( Fig. la and Table  1 ). From these analyses we have classified the EA2 and ET cell lines as thymic cortical epithelial cells and the EB3 line as medullary epithelial cells.
We have also characterized EA2, EB3, and ET thymic epithelial lines as to the synthesis of RNA for various interleukins. Northern blot analysis showed that EA2 and ET cells but not EB3 cells produce RNA transcripts from the IL-7 gene, whereas EB3 epithelial cells synthesized RNA from the IL-la gene. None of the three epithelial cell lines produces detectable RNA transcripts for IL-2, IL-3, IL-4, or IL-6 ( Fig. lb and data not shown) . RNA from all three epithelial lines hybridized to a f3-actin probe (Fig. lb) . The synthesis of RNA for IL-7 and/or IL-la by EA2, ET, and EB3 epithelial cells is of potential significance because these cytokines were found to contribute to growth in vitro of thymocytes (24) (25) (26) . The other two known growth factors for thymocytes, IL-2 and IL-4, are produced by the developing thymocytes themselves (27, 28) . The presence of IL-7 RNA transcripts in the thymus has been reported (29) , but the cell types producing IL-7 mRNA were not identified. Our results identify cortical thymic epithelial cells as one of the cell types in thymus capable of producing this IL.
The capacity of epithelial cells to promote T-cell differentiation was assessed in vivo by injecting these cells directly into the spleens of young athymic nude mice and assessing by two-color flow cytometry analysis the presence of mature CD4+, CD8+, and TCR+CD3+ T lymphocytes in the spleens at various times thereafter (for details see Materials and Methods). Young (3-4 weeks old) athymic nude mice are used because at that age the spleens of these animals contain T-cell progenitors but no mature T lymphocytes. We result in the lack ofmature T and B lymphocytes and deficient natural killer cell function (30, 31) ; (ii) BALB/c Nu/Nu; and (iii) C57BL/6 Nu/Nu mice, which are deficient in T lymphocytes but have B lymphocytes and normal natural killer function (32) . Fig. 2a illustrates these results in the form of contour plots with one example for each group, and Table 2 Proc. Natl. Acad. Sci. USA 88 (1991) 645 summarizes the results. Spleens from nude mice that had received the EA2 cortical epithelial cells contained CD4+ CD8-and CD4-CD8+ cells, up to 97% of which were also TCRa,8f CD3+. The few (2-5.7%) CD3+ lymphocytes that did not bind the pan-TCRa,3-specific antibody H57-597 are probably TCRy6+ T cells. The spleens from the nude mice that had received ET cortical epithelial cells contained CD4+CD8-but not CD4-CD8+ cells. Most CD4+ cells (>97%) were TCRa,8f CD3+, and between 1.5% and 5.2%
CD3+ cells were TCRac-(i.e., they were presumably TCRy6+). During these experiments the GL3 anti-panTCRy6 monoclonal antibody (33) became available, and we could formally determine that TCRy6+ lymphocytes were generated in spleens from nude mice that had received the EA2 or ET epithelial cells (six mice per group were tested, and the results are included in Table 2 The results summarized in Table 3 show that spleen cells from nude mice that had received EA2 or ET cortical epithelial Capacity of epithelial cell lines EA2, ET, and EB3 to promote T-cell differentiation in vivo was studied by directly injecting these cells into spleens of 3-to 4-week-old athymic nude mice. Splenocytes positive for the surface markers were determined by two-color flow cytometry analysis weekly at various times (from 1 to 8 weeks); percentages shown are the ranges seen for each group. Analysis of percentages of CD4+ or CD8+ cells, coexpressing TCRa,8 or CD3, showed that most (up to 97%) CD4+ or CD8+ cells were also TCRa.3' CD3+; few (up to 3%) CD4+ or CD8+ cells that did not bear TCRaB or CD3 were also regularly found. TCRy8+ cells were initially considered those lymphocytes that were CD3+ but did not bind the pan-TCRa/8 monoclonal antibody. As pan-TCRyS antibody GL3 became available, we counted as TCRyS5 cells those lymphocytes that bound both GL3-and CD3-specific antibodies (6 mice of each group indicated above were so tested). For brevity, the data from athymic nude mice not injected with epithelial cell lines are not shown, as a more appropriate control was the nude mice that received EB3 epithelial line, which does not support T-cell differentiation. *Spleen cells were analyzed by flow cytometry. cells proliferated in response to CD3 E-chain-specific antibody or to the T-cell mitogen Con A. In contrast, spleen cells from nude mice that had received EB3 medullary epithelial cells or that were left untreated did not show these responses.
Taken together, the results show that ET cortical epithelial cells promote in vivo, like they do in vitro (10), differentiation of T-cell progenitors into CD4+CD8-TCRaf3+ CD3+ and TCR'y8+ CD3+ lymphocytes but not into CD4-CD8+ or CD4+CD8+ cells. EA2 cortical epithelial line supports development of CD4+CD8-and CD4-CD8+ TCRaf3+ CD3+ and TCRy8+ CD3+ cells but not CD4+CD8+ cells. EB3 medullary epithelial cells do not promote T-cell differentiation. The finding that CD4+CD8+ cells were not seen at any time studied in the athymic nude mice that had received EA2 or ET cortical epithelial cells was intriguing because CD4+ CD8+ thymocytes are currently regarded as an intermediate stage of development between CD4-CD8-early T cells and mature CD4+CD8-or CD4-CD8+ lymphocytes (34) (35) (36) (37) . However, CD4+CD8-and CD4-CD8+ TCR/CD3+ lymphocytes can develop with and without passing through a CD4+CD8+ intermediate stage (10) . The conditions used here only fulfilled the requirements for CD4+CD8-and/or CD4-CD8+ cells to develop directly from CD4-CD8-T-cell precursors. Development into CD4+CD8+ cells must require other types of thymic epithelial cells and/or other thymic components that were not met in the experimental system used here.
In our previous study in vitro (10) , the ET cell line supported differentiation of pro-T-lymphocyte clones into CD4+CD8-TCRa,3+ CD3+ cells but failed to promote the generation of CD4+CD8+ cells. Nor did it induce purified CD4+CD8+ thymocytes from adult mice to differentiate into CD4+CD8-or CD4-CD8+ cells (10) , suggesting that the requirements for CD4-CD8-pro-T cells and CD4+CD8+ thymocytes to generate mature T lymphocytes must differ. The in vivo findings described here and those in vitro reported previously (10) show the ability of thymic cortical epithelial cells to promote the first phase of T-cell development and provide direct evidence for functionally distinct subpopulations of cortical epithelial cells. The experimental system described here may also prove valuable to study further the role of thymic epithelial cells in the second phase of T-cell development-i.e., positive and negative selection of TCR/CD3+ developing thymocytes.
